Streetbeat News

Stock Prices

VRDN

Nine analysts have given their ratings on Viridian Therapeutics (NASDAQ:VRDN) over the last quarter, with three being bullish, six somewhat bullish, and none being bearish or indifferent. The average price target is $44.0, indicating a potential upside from the current price of $19.58.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:00 pm

JAMF

In the last quarter, Jamf Holding (NASDAQ:JAMF) received 7 analyst ratings, with 5 being bullish, 2 somewhat bullish, and none being bearish or indifferent. The average price target for the stock is $32.0, a significant increase from the previous average of $23.00, indicating a potential upside from the current price of $17.73.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:00 pm

CUTR

Cutera's shares are trading lower following the company's Q2 financial results, which were worse than expected.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:00 pm

V

Visa (NYSE:V) has outperformed the market over the past 15 years, producing an average annual return of 18.49%. If an investor had bought $100 of V stock 15 years ago, it would be worth $1,305.53 today. The company currently has a market capitalization of $501.87 billion.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:00 pm

FCX

Freeport-McMoRan (NYSE:FCX) has outperformed the market over the past 5 years, producing an average annual return of 23.93%. An investment of $1000 in FCX 5 years ago would be worth $2,898.46 today. The company currently has a market capitalization of $61.98 billion.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:00 pm

MRVI

Analysts have provided various ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter, with 1 bullish, 3 somewhat bullish, and 3 indifferent. The average 12-month price target for the company is $13.0, representing a 31.07% decrease from the previous average price target of $18.86.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:00 pm

LINKUSD

Chainlink's (CRYPTO: LINK) price has risen 6.3% to $7.8 in the past 24 hours, continuing its positive trend over the past week with a 2.0% gain. The trading volume for the coin has increased 39.0% over the past week while the overall circulating supply of the coin has increased 0.13% to over 538.10 million. The current market cap ranking for LINK is #21 at $4.21 billion.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:00 pm

GPAK

Gamer Pakistan Inc (NASDAQ:GPAK) is set to IPO on August 10, with shares expected to be priced between $4.00 and $5.00. The company, which focuses on promoting esports events and product marketing, has an insider lock-up period of 180 days ending on February 06, 2024.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:00 pm

BLFS

BioLife Solutions reported worse-than-expected Q2 financial results and issued FY23 revenue guidance below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:00 pm

EGHT

8x8 Inc. reported lower than expected Q2 sales results and issued Q2 2024 revenue guidance below estimates, leading to a drop in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 2:59 pm